ABBOTT LABORATORIES

Pharmaceutical Preparations·ABBOTT PARK, IL·FY end 12/31·CIK 1800

Named Executive Officers

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Robert B. Ford Chairman of the Board and Chief Executive Officer	$1.5M	$8.8M	$8.8M	$2.0M	$3.2M	$24.2M
Philip P. Boudreau Executive Vice President, Finance and Chief Financial Officer	$974.2K	$3.0M	$3.0M	$1.1M	$968.7K	$9.1M
Lisa D. Earnhardt Executive Vice President and Group President, Medical Devices	$924.2K	$2.5M	$2.5M	$1.3M	$773.7K	$8.1M
Christopher J. Scoggins Executive Vice President, Diabetes Care	$859.5K	$1.7M	$1.7M	$1.1M	$1.3M	$6.6M
Daniel G. Salvadori Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products	$924.2K	$2.2M	$2.2M	$388.2K	$744.0K	$6.5M

Robert B. Ford · FY 2025

Stock awards$8.8M36%

Performance bonus$2.0M8%

Salary$1.5M6%

Other$11.9M49%

TSR % vs. CEO comp actually paid · 5 fiscal years · Item 402(v) disclosure

TSR

CEO comp

FY21

+67%

$43M

FY22

+33%

$8M

FY23

+36%

$20M

FY24

+42%

$25M

FY25

+25%

$27M

Need at least two fiscal years of proxy data to draw the trend line. The ingestion worker will populate prior-year proxies as it processes them.